FBIO earnings date and last-quarter result: next report 2026-08-13, last quarter beat, P/E 0.92. Updated 2026-07-23.
Fortress Biotech (FBIO) Research Hub
Fortress Biotech (FBIO) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 1.87 USD (-3.11%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 0.92, market cap 0.12B. This hub links to the full technical, earnings and options research available for FBIO.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 1.87 USD (-3.11%) |
| 52-week range | 1.83 USD – 3.84 USD |
| Trend regime | Range |
| 14-day RSI | 35.5 (Bearish) |
| Trailing P/E | 0.92 |
| Market cap | 0.12B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-13 |
Available research for FBIO
Covered Call on FBIO: how it works, illustrative setup around the real 1.87 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on FBIO: how it works, illustrative setup around the real 1.87 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on FBIO: how it works, illustrative setup around the real 1.87 USD price, max profit/loss, breakeven and when to use it. Educational.
FBIO technical analysis: range, last 1.87 USD, RSI 35.5, 52w range 1.83 USD–3.84 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is FBIO in?
Fortress Biotech (FBIO) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is FBIO in an uptrend or downtrend?
As of 2026-10-26, FBIO is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is FBIO's trailing P/E ratio?
FBIO's trailing P/E is 0.92, with a market cap of 0.12B. See the earnings research page for full valuation detail.
When does FBIO next report earnings?
FBIO is next scheduled to report earnings on 2026-08-13.